Market Closed -
Nyse
04:00:02 2024-06-07 pm EDT
|
5-day change
|
1st Jan Change
|
88.79
USD
|
+0.50%
|
|
-1.20%
|
+7.62%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
38,830
|
31,238
|
38,627
|
44,731
|
48,211
|
50,452
|
-
|
-
|
Enterprise Value (EV)
1 |
38,830
|
31,238
|
38,627
|
44,731
|
52,772
|
55,627
|
55,732
|
55,837
|
P/E ratio
|
11.9
x
|
6.67
x
|
9.14
x
|
10.9
x
|
10.6
x
|
11.1
x
|
13.2
x
|
12.5
x
|
Yield
|
2.04%
|
2.52%
|
2.26%
|
2.22%
|
2.04%
|
2.26%
|
2.3%
|
2.5%
|
Capitalization / Revenue
|
1.74
x
|
1.41
x
|
1.75
x
|
2.29
x
|
2.58
x
|
2.87
x
|
2.83
x
|
2.78
x
|
EV / Revenue
|
1.74
x
|
1.41
x
|
1.75
x
|
2.29
x
|
2.82
x
|
3.17
x
|
3.13
x
|
3.08
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
10.3
x
|
9.58
x
|
9.47
x
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
18.5
x
|
18.6
x
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
5.39%
|
5.38%
|
-
|
Price to Book
|
1.33
x
|
0.92
x
|
1.15
x
|
1.98
x
|
2.17
x
|
2.12
x
|
2.04
x
|
1.95
x
|
Nbr of stocks (in thousands)
|
734,018
|
702,445
|
661,528
|
621,789
|
584,380
|
568,222
|
-
|
-
|
Reference price
2 |
52.90
|
44.47
|
58.39
|
71.94
|
82.50
|
88.79
|
88.79
|
88.79
|
Announcement Date
|
2/4/20
|
2/3/21
|
2/2/22
|
2/1/23
|
1/31/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
22,307
|
22,147
|
22,106
|
19,502
|
18,701
|
17,555
|
17,818
|
18,130
|
EBITDA
1 |
-
|
-
|
-
|
-
|
5,126
|
5,805
|
5,882
|
-
|
EBIT
1 |
4,445
|
4,159
|
5,322
|
4,157
|
4,310
|
4,824
|
4,812
|
-
|
Operating Margin
|
19.93%
|
18.78%
|
24.07%
|
21.32%
|
23.05%
|
27.48%
|
27.01%
|
-
|
Earnings before Tax (EBT)
1 |
4,445
|
4,159
|
5,322
|
4,604
|
5,262
|
5,581
|
4,830
|
4,544
|
Net income
1 |
3,304
|
4,778
|
4,325
|
4,201
|
4,659
|
4,544
|
3,612
|
3,618
|
Net margin
|
14.81%
|
21.57%
|
19.56%
|
21.54%
|
24.91%
|
25.88%
|
20.27%
|
19.95%
|
EPS
2 |
4.430
|
6.670
|
6.390
|
6.590
|
7.780
|
8.024
|
6.733
|
7.080
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-
|
3,000
|
3,000
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
17.09%
|
16.84%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
51.68%
|
51%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
66.02%
|
83.06%
|
-
|
Dividend per Share
2 |
1.080
|
1.120
|
1.320
|
1.600
|
1.680
|
2.006
|
2.042
|
2.217
|
Announcement Date
|
2/4/20
|
2/3/21
|
2/2/22
|
2/1/23
|
1/31/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
5,433
|
5,272
|
5,400
|
4,820
|
4,010
|
4,800
|
5,172
|
4,950
|
3,777
|
5,436
|
4,351
|
4,356
|
4,366
|
4,441
|
4,447
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,499
|
947
|
1,378
|
1,439
|
1,436
|
1,413
|
1,440
|
1,469
|
EBIT
1 |
1,233
|
1,143
|
1,134
|
880
|
1,001
|
1,133
|
1,139
|
1,298
|
739
|
1,163
|
1,200
|
1,214
|
1,158
|
1,229
|
1,258
|
Operating Margin
|
22.69%
|
21.68%
|
21%
|
18.26%
|
24.96%
|
23.6%
|
22.02%
|
26.22%
|
19.57%
|
21.39%
|
27.58%
|
27.88%
|
26.54%
|
27.67%
|
28.29%
|
Earnings before Tax (EBT)
1 |
1,233
|
1,276
|
1,701
|
1,103
|
524
|
1,342
|
1,825
|
1,805
|
289
|
2,170
|
1,267
|
1,274
|
1,240
|
1,440
|
1,469
|
Net income
1 |
1,039
|
1,032
|
1,388
|
1,596
|
185
|
1,188
|
1,634
|
1,569
|
268
|
1,879
|
889.5
|
895
|
847.8
|
898.5
|
881.8
|
Net margin
|
19.12%
|
19.58%
|
25.7%
|
33.11%
|
4.61%
|
24.75%
|
31.59%
|
31.7%
|
7.1%
|
34.57%
|
20.45%
|
20.55%
|
19.42%
|
20.23%
|
19.83%
|
EPS
2 |
1.570
|
1.580
|
2.160
|
2.530
|
0.3000
|
1.940
|
2.710
|
2.640
|
0.4600
|
3.250
|
1.564
|
1.602
|
1.534
|
1.654
|
1.650
|
Dividend per Share
2 |
0.3300
|
0.4000
|
0.4000
|
0.4000
|
0.4000
|
0.4200
|
0.4200
|
0.4200
|
0.4200
|
0.5000
|
0.4850
|
0.4850
|
0.4925
|
0.5275
|
0.5275
|
Announcement Date
|
2/2/22
|
4/27/22
|
8/1/22
|
10/31/22
|
2/1/23
|
4/26/23
|
8/1/23
|
11/1/23
|
1/31/24
|
5/1/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
4,561
|
5,175
|
5,279
|
5,385
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
0.8898
x
|
0.8914
x
|
0.8975
x
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-
|
3,000
|
3,000
|
-
|
ROE (net income / shareholders' equity)
|
12.6%
|
15.3%
|
12.9%
|
12.9%
|
13.8%
|
15%
|
14.7%
|
14.3%
|
ROA (Net income/ Total Assets)
|
-
|
3.01%
|
2.49%
|
2.35%
|
3.61%
|
3.07%
|
3.04%
|
-
|
Assets
1 |
-
|
158,927
|
173,596
|
178,424
|
129,230
|
148,205
|
119,010
|
-
|
Book Value Per Share
2 |
39.80
|
48.50
|
51.00
|
36.40
|
38.00
|
41.80
|
43.60
|
45.60
|
Cash Flow per Share
|
-
|
8.320
|
7.460
|
6.080
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/4/20
|
2/3/21
|
2/2/22
|
2/1/23
|
1/31/24
|
-
|
-
|
-
|
Last Close Price
88.79
USD Average target price
85.25
USD Spread / Average Target -3.99% Consensus |
1st Jan change
|
Capi.
|
---|
| +7.62% | 50.45B | | +5.93% | 49.81B | | +21.55% | 46.31B | | +13.62% | 42.31B | | +24.52% | 39.83B | | -1.75% | 28.46B | | -8.98% | 27.07B | | +27.21% | 26.32B | | -17.54% | 25.51B | | +34.36% | 24.17B |
Other Life & Health Insurance
|